|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, Zeng H, Xia C,
Zuo T, Yang Z, Zou X and He J: Cancer incidence and mortality in
China 2013. Cancer Lett. 401:63–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scher HI, Solo K, Valant J, Todd MB and
Mehra M: Prevalence of prostate cancer clinical states and
mortality in the United States: Estimates using a dynamic
progression model. PLoS One. 10:e01394402015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye D and Zhu Y: Epidemiology of prostate
cancer in China: An overview and clinical implication. Zhonghua Wai
Ke Za Zhi. 53:249–252. 2015.(In Chinese). PubMed/NCBI
|
|
6
|
Attard G, Parker C, Eeles RA, Schröder F,
Tomlins SA, Tannock I, Drake CG and de Bono JS: Prostate cancer.
Lancet. 387:70–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watson PA, Arora VK and Sawyers CL:
Emerging mechanisms of resistance to androgen receptor inhibitors
in prostate cancer. Nat Rev Cancer. 15:701–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schepisi G, Farolfi A, Conteduca V,
Martignano F, De Lisi D, Ravaglia G, Rossi L, Menna C, Bellia SR,
Barone D, et al: Immunotherapy for prostate cancer: Where we are
headed. Int J Mol Sci. 18:E26272017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schrecengost R and Knudsen KE: Molecular
pathogenesis and progression of prostate cancer. Semin Oncol.
40:244–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin J, Fu W, Dai L, Jiang Z, Liao H, Chen
W, Pan L and Zhao J: ANKRD22 promotes progression of non-small cell
lung cancer through transcriptional up-regulation of E2F1. Sci Rep.
7:44302017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hennink I, van Leeuwen MW, Penning LC and
Piek CJ: Increased number of tissue factor protein expressing
thrombocytes in canine idiopathic immune mediated hemolytic anemia.
Vet Immunol Immunopathol. 196:22–29. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J, Chen Y, Xiong X, Zhou X, Han L, Ni
L, Wang W, Wang X, Zhao L, Shao D and Huang C: Peptidome analysis
reveals novel serum biomarkers for children with autism spectrum
disorder in China. Proteomics Clin Appl. 12:e17001642018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roell W, Klein AM, Breitbach M, Becker TS,
Parikh A, Lee J, Zimmermann K, Reining S, Gabris B, Ottersbach A,
et al: Overexpression of Cx43 in cells of the myocardial scar:
Correction of post-infarct arrhythmias through heterotypic
cell-cell coupling. Sci Rep. 8:71452018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fragiadaki M and Zeidler MP: Ankyrin
repeat and single KH domain 1 (ANKHD1) drives renal cancer cell
proliferation via binding to and altering a subset of miRNAs. J
Biol Chem. 293:9570–9579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bai R, Li D, Shi Z, Fang X, Ge W and Zheng
S: Clinical significance of Ankyrin repeat domain 12 expression in
colorectal cancer. J Exp Clin Cancer Res. 32:352013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wissing ML, Kristensen SG, Andersen CY,
Mikkelsen AL, Høst T, Borup R and Grøndahl ML: Identification of
new ovulation-related genes in humans by comparing the
transcriptome of granulosa cells before and after ovulation
triggering in the same controlled ovarian stimulation cycle. Hum
Reprod. 29:997–1010. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chakrabarty B and Parekh N: Identifying
tandem Ankyrin repeats in protein structures. BMC Bioinformatics.
15:65992014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miller MK, Bang ML, Witt CC, Labeit D,
Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC and
Labeit S: The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and
DARP as a family of titin filament-based stress response molecules.
J Mol Biol. 333:951–964. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parra RG, Espada R, Verstraete N and
Ferreiro DU: Structural and energetic characterization of the
ankyrinrepeat protein family. PLoS Comput Biol. 11:e10046592015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tanno H, Yamaguchi T, Goto E, Ishido S and
Komada M: The Ankrd 13 family of UIM-bearing proteins regulates EGF
receptor endocytosis from the plasma membrane. Mol Biol Cell.
23:1343–1353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wette SG, Smith HK, Lamb GD and Murphy RM:
Characterization of muscle ankyrin repeat proteins in human
skeletal muscle. Am J Physiol Cell Physiol. 313:C327–C339. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan W, Sun K, Tang K, Xiao Q, Ma C, Yu C
and Wei Z: Structural insights into ankyrin repeat-mediated
recognition of the kinesin motor protein KIF21A by KANK1, a
scaffold protein in focal adhesion. J Biol Chem. 293:1944–1956.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Venner JM, Famulski KS, Badr D, Hidalgo
LG, Chang J and Halloran PF: Molecular landscape of T cell-mediated
rejection in human kidney transplants: Prominence of CTLA4 and PD
ligands. Am J Transplant. 14:2565–2576. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
VanDussen KL, Carulli AJ, Keeley TM, Patel
SR, Puthoff BJ, Magness ST, Tran IT, Maillard I, Siebel C, Kolterud
Å, et al: Notch signaling modulates proliferation and
differentiation of intestinal crypt base columnar stem cells.
Development. 139:488–497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lubman OY, Korolev SV and Kopan R:
Anchoringnotchgenetics and biochemistry; structural analysis of the
ankyrin domain sheds light on existing data. Mol Cell. 13:619–626.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huan YW, Bengtsson RJ, MacIntyre N,
Guthrie J, Finlayson H, Smith SH, Archibald AL and Ait-Ali T:
Lawsonia intracellularis exploits β-catenin/Wnt and Notch
signalling pathways during infection of intestinal crypt to alter
cell homeostasis and promote cell proliferation. PLoS One.
12:e01737822017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Jonge HJ, Woolthuis CM, Vos AZ, Mulder
A, van den Berg E, Kluin PM, van der Weide K, de Bont ES, Huls G,
Vellenga E and Schuringa JJ: Gene expression profiling in the
leukemic stem cell-enriched CD34+ fraction identifies
target genes that predict prognosis in normal karyotype AML.
Leukemia. 25:1825–1833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu L, Tong X, Zhang S, Yin F, Li X, Wei H,
Li C, Guo Y and Zhao J: ASPP2 suppresses stem cell-like
characteristics and chemoresistance by inhibiting the Src/FAK/Snail
axis in hepatocellular carcinoma. Tumour Biol. 37:13669–13677.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lahiani A, Zahavi E, Netzer N, Ofir R,
Pinzur L, Raveh S, Arien-Zakay H, Yavin E and Lazarovici P: Human
placental eXpanded (PLX) mesenchymal-like adherent stromal cells
confer neuroprotection to nerve growth factor (NGF)-differentiated
PC12 cells exposed to ischemia by secretion of IL-6 and VEGF.
Biochim Biophys Acta. 1853:422–430. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang L, Ju X, Cheng Y, Guo X and Wen T:
Identifying Tmem59 related gene regulatory network of mouse neural
stem cell from a compendium of expression profiles. BMC Syst Biol.
5:1522011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hino S, Michiue T, Asashima M and Kikuchi
A: Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1
and is essential for Wnt-3a-induced accumulation of beta-catenin. J
Biol Chem. 278:14066–14073. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schoenborn JR, Nelson P and Fang M:
Genomic profiling defines subtypes of prostate cancer with the
potential for therapeutic stratification. Clin Cancer Res.
19:4058–4066. 2013. View Article : Google Scholar : PubMed/NCBI
|
